Roswell Park Cancer Institute

Roswell Park Cancer Institute was paid $36.69M by Medicaid between Jan 2018 and Nov 2024, across 242 billing codes. Its largest line is J9271, Injection, pembrolizumab, 1 mg — 19% of everything it billed.

33Billing provider infoROSWELL PARK CANCER INSTITUTE
BUFFALO, NY 14263

33aNPI1548315401assigned 01/23/2007

33bProvider typeGeneral Acute Care Hospital

28Total paid$36.69M

24GClaims400,041

24DCodes billed242

24AFirst – last monthJan 2018 – Nov 2024

Compared with peers

Next to other General Acute Care Hospital providers in New York

Rank by total paid#39 of 231

Median peer was paid$561K

This provider vs. median65×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	633	$74K
2019	27,891	$2.27M
2020	73,647	$6.17M
2021	84,677	$8.98M
2022	69,842	$6.25M
2023	86,314	$7.67M
2024incomplete	57,037	$5.29M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
J9271	Injection, pembrolizumab, 1 mg	19%	749	630	$7.13M
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	13%	18,483	16,072	$4.77M
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	11%	16,200	14,131	$4.06M
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	8.4%	10,345	5,817	$3.08M
78815	Positron emission tomography (PET) for limited area imaging	4.1%	1,407	1,399	$1.49M
80053	Comprehensive metabolic panel	3.5%	35,061	22,264	$1.29M
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	3.0%	4,581	4,186	$1.11M
71260	Computed tomography, thorax, diagnostic; with contrast material	1.9%	5,022	4,976	$715K
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	1.9%	2,214	1,599	$688K
70553	Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences	1.8%	2,160	2,075	$670K
86850		1.6%	7,495	5,313	$596K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	1.6%	3,018	2,753	$573K

230 more codes

74177	Computed tomography, abdomen and pelvis; with contrast material	1.5%	3,885	$568K
77336		1.4%	2,330	$522K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	1.2%	3,102	$432K
P9040	Red blood cells, leukocytes reduced, irradiated, each unit	1.1%	1,800	$404K
J0185	Injection, aprepitant, 1 mg	<1%	1,149	$362K
77412		<1%	1,546	$347K
36415	Collection of venous blood by venipuncture	<1%	33,428	$330K
31575		<1%	767	$320K
96409		<1%	1,025	$303K
96375	Therapeutic injection; each additional sequential IV push	<1%	5,861	$269K
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	<1%	1,450	$240K
96361	Intravenous infusion, hydration; each additional hour	<1%	1,290	$239K
Q3014	Telehealth originating site facility fee	<1%	877	$222K
77386		<1%	640	$216K
96411		<1%	1,466	$202K
82565		<1%	1,465	$200K
J9306	Injection, pertuzumab, 1 mg	<1%	36	$197K
J2469	Injection, palonosetron hcl, 25 mcg	<1%	2,478	$187K
36430		<1%	1,844	$182K
G0463	Hospital outpatient clinic visit for assessment and management of a patient	<1%	3,766	$177K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	31,822	$164K
77067	Screening mammography, bilateral, including computer-aided detection	<1%	2,268	$160K
71250		<1%	1,381	$145K
J3490	Unclassified drugs	<1%	2,182	$144K
88185		<1%	1,340	$140K
A9552	Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries	<1%	730	$136K
77049		<1%	426	$123K
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	<1%	950	$121K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	4,549	$121K
96402		<1%	473	$118K
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	355	$110K
80048	Basic metabolic panel (calcium, ionized)	<1%	1,641	$109K
Q5111	Injection, pegfilgrastim-cbqv (udenyca), biosimilar, 0.5 mg	<1%	28	$100K
99215	Doctor's office visit, returning patient (complex)	<1%	388	$98K
96417		<1%	2,325	$97K
88341		<1%	1,306	$96K
96415		<1%	2,115	$92K
J1950	Injection, leuprolide acetate (for depot suspension), per 3.75 mg	<1%	49	$88K
J9305	Injection, pemetrexed, not otherwise specified, 10 mg	<1%	12	$87K
77066	Tomosynthesis, mammo	<1%	957	$84K
77063	Screening digital breast tomosynthesis, bilateral	<1%	2,268	$82K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	2,897	$81K
77334		<1%	590	$72K
J9045	Injection, carboplatin, 50 mg	<1%	1,117	$67K
77300		<1%	453	$67K
86923		<1%	1,496	$65K
96367		<1%	386	$65K
11102		<1%	149	$64K
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	<1%	666	$62K
70491		<1%	463	$60K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	556	$57K
0202U	Oncology (prostate), multianalyte, gene expression profiling	<1%	268	$50K
83521		<1%	387	$50K
76642		<1%	1,111	$47K
0002A		<1%	272	$46K
87631		<1%	738	$44K
76536		<1%	847	$42K
36561		<1%	26	$41K
83615		<1%	13,189	$37K
77065	Tomosynthesis, mammo	<1%	540	$37K
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	499	$33K
77280		<1%	99	$31K
J9267	Injection, paclitaxel, 1 mg	<1%	475	$29K
76942		<1%	392	$27K
J7050	Infusion, normal saline solution, 250 cc	<1%	3,403	$27K
88342		<1%	1,779	$27K
85027		<1%	5,674	$26K
J9070	Cyclophosphamide, 100 mg	<1%	47	$26K
82378		<1%	2,119	$26K
84443	Thyroid stimulating hormone (TSH)	<1%	3,228	$25K
45378	Colonoscopy, flexible; diagnostic, including collection of specimen(s)	<1%	13	$24K
82728		<1%	3,237	$24K
84436		<1%	1,340	$24K
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	<1%	12	$24K
86900		<1%	7,704	$22K
82784		<1%	1,478	$22K
J7030	Infusion, normal saline solution , 1000 cc	<1%	3,889	$21K
74183		<1%	52	$19K
88184		<1%	1,324	$19K
J1642	Injection, heparin sodium, (heparin lock flush), per 10 units	<1%	2,079	$19K
86901		<1%	7,707	$19K
85007		<1%	5,820	$18K
83735		<1%	5,945	$18K
38222		<1%	53	$17K
36593		<1%	59	$17K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	1,676	$17K
74178		<1%	94	$16K
86304		<1%	581	$15K
88360		<1%	473	$15K
78306		<1%	119	$15K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	1,171	$14K
84550		<1%	5,651	$14K
J7060	5% dextrose/water (500 ml = 1 unit)	<1%	2,109	$14K
81025		<1%	1,403	$13K
84100		<1%	4,930	$12K
87486		<1%	480	$12K
88307		<1%	455	$11K
82948		<1%	264	$11K
0001A		<1%	91	$11K
84432		<1%	108	$11K
71046	Radiologic examination, chest; 2 views	<1%	636	$11K
J8540	Dexamethasone, oral, 0.25 mg	<1%	2,657	$11K
J2997	Injection, alteplase recombinant, 1 mg	<1%	56	$11K
90686		<1%	569	$10K
84153		<1%	410	$10K
G0279	Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066)	<1%	306	$10K
83020		<1%	1,598	$9K
J0640	Injection, leucovorin calcium, per 50 mg	<1%	86	$9K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	569	$9K
93010	Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only	<1%	1,162	$9K
87088		<1%	909	$8K
94010		<1%	127	$8K
86300		<1%	872	$8K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	468	$8K
86902		<1%	239	$7K
J2704	Injection, propofol, 10 mg	<1%	2,476	$7K
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	3,881	$7K
87496		<1%	513	$7K
J9370	Vincristine sulfate, 1 mg	<1%	578	$7K
86334		<1%	530	$6K
85610		<1%	1,534	$6K
87497		<1%	95	$6K
85045		<1%	3,544	$5K
84484		<1%	802	$5K
88112		<1%	197	$5K
97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	<1%	80	$5K
77295		<1%	24	$5K
87581		<1%	481	$5K
94729		<1%	215	$5K
83880		<1%	231	$4K
81003		<1%	2,216	$4K
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	2,373	$4K
81206		<1%	40	$4K
87040		<1%	504	$4K
76641		<1%	66	$4K
84480		<1%	1,406	$4K
J1170	Injection, hydromorphone, up to 4 mg	<1%	1,126	$4K
Q0162	Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen	<1%	2,318	$4K
C1788	Port, indwelling (implantable)	<1%	24	$4K
94726		<1%	170	$3K
74176	Computed tomography, abdomen and pelvis; without contrast material	<1%	47	$3K
J3489	Injection, zoledronic acid, 1 mg	<1%	41	$3K
J9201	Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg	<1%	42	$3K
J2545	Pentamidine isethionate, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 300 mg	<1%	19	$3K
J9000	Injection, doxorubicin hydrochloride, 10 mg	<1%	55	$3K
86704		<1%	394	$3K
97162		<1%	42	$2K
84165		<1%	584	$2K
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	3,693	$2K
83605		<1%	473	$2K
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	3,232	$2K
87070		<1%	333	$2K
77080		<1%	57	$2K
71271		<1%	52	$2K
84439		<1%	128	$2K
85046		<1%	817	$2K
82105		<1%	185	$2K
83883		<1%	102	$2K
94060		<1%	24	$2K
86803		<1%	435	$2K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	118	$2K
87340		<1%	403	$2K
82607		<1%	265	$2K
81450		<1%	41	$1K
85097		<1%	63	$1K
J0131	Injection, acetaminophen, not otherwise specified,10 mg	<1%	100	$1K
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	3,609	$1K
D0120	Dental checkup, returning patient	<1%	24	$1K
85730		<1%	367	$1K
J1453	Injection, fosaprepitant, 1 mg	<1%	14	$1K
86140		<1%	416	$1K
77001		<1%	40	$1K
86706		<1%	163	$1K
83921		<1%	30	$1K
70487		<1%	13	$957.26
83540		<1%	488	$949.36
83550		<1%	472	$911.24
76937		<1%	40	$867.26
71045	Radiologic examination, chest; single view	<1%	99	$852.04
87077		<1%	47	$751.14
88237		<1%	12	$728.88
J7040	Infusion, normal saline solution, sterile (500 ml = 1 unit)	<1%	77	$686.68
J3475	Injection, magnesium sulfate, per 500 mg	<1%	307	$685.30
82550		<1%	100	$684.90
85660		<1%	195	$675.15
J0690	Injection, cefazolin sodium, 500 mg	<1%	394	$664.24
J8499	Prescription drug, oral, non chemotherapeutic, nos	<1%	1,732	$656.04
86800		<1%	135	$649.78
J1644	Injection, heparin sodium, per 1000 units	<1%	637	$622.52
88142		<1%	39	$614.38
90472	Immunization administration, each additional vaccine (list separately)	<1%	57	$496.64
81015		<1%	1,002	$409.01
87205		<1%	201	$321.11
A9503	Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries	<1%	24	$313.40
J9250	Methotrexate sodium, 5 mg	<1%	169	$309.56
88162		<1%	53	$306.78
88108		<1%	29	$260.54
86301		<1%	25	$259.00
87799		<1%	14	$237.95
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	<1%	13	$236.54
J1720	Injection, hydrocortisone sodium succinate, up to 100 mg	<1%	18	$213.52
94642		<1%	17	$208.73
88311		<1%	38	$175.97
83090		<1%	17	$172.34
82668		<1%	14	$149.89
88313		<1%	12	$139.28
J3420	Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg	<1%	40	$139.07
80061	Lipid panel	<1%	29	$134.04
82248		<1%	58	$127.67
85651		<1%	157	$126.41
84157		<1%	81	$125.92
82945		<1%	83	$125.30
82570		<1%	67	$112.17
89050		<1%	82	$106.83
83021		<1%	14	$104.24
82747		<1%	12	$95.16
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	13	$90.25
86703		<1%	17	$85.51
87186		<1%	15	$77.73
83690		<1%	31	$70.64
89051		<1%	31	$64.88
Q0164	Prochlorperazine maleate, 5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen	<1%	116	$61.82
J0330	Injection, succinylcholine chloride, up to 20 mg	<1%	47	$60.97
85652		<1%	58	$54.21
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	69	$49.02
82150		<1%	31	$45.19
Q0163	Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen	<1%	1,215	$42.85
S0028	Injection, famotidine, 20 mg	<1%	46	$42.56
84156		<1%	14	$18.35
J7613	Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg	<1%	41	$2.52

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialJOHNSON, CANDACE (PRESIDENT AND CEO)

Same official

Other billing entities under JOHNSON, CANDACE

Full network →

Provider	Location	Paid
Roswell Park Cancer Institute	Buffalo, NY	$740K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.